Dr. Udaya Kumar, MD
What this data tells you about Dr. Kumar
Dr. Udaya Kumar is an urology physician in Lecanto, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kumar performed 4,730 Medicare services across 3,010 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kumar received a total of $16,718 from 35 pharmaceutical and/or device companies across 97 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kumar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis | 1,322 | $2 | $5 |
| Office visit, established patient (20-29 min) | 727 | $63 | $227 |
| Office visit, established patient (30-39 min) | 533 | $91 | $320 |
| Bladder ultrasound after voiding | 449 | $8 | $26 |
| Blood draw (venipuncture) | 393 | $6 | $6 |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 301 | $1 | $3 |
| Chronic care management, first 20 min/month | 208 | $48 | $159 |
| New patient office visit (45-59 min) | 144 | $118 | $422 |
| Diagnostic exam of bladder and urethra using an endoscope | 113 | $57 | $207 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 58 | $135 | $336 |
| Ultrasound scan of pelvic region through rectum | 42 | $24 | $72 |
| Drug injection, under skin or into muscle | 39 | $10 | $35 |
| Mri scan of pelvis before and after contrast | 36 | $133 | $354 |
| Mri scan of pelvis without contrast | 35 | $92 | $242 |
| Simple insertion of temporary bladder tube | 34 | $47 | $156 |
| Hospital follow-up visit, low complexity | 33 | $39 | $98 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 29 | $25 | $81 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 29 | $68 | $256 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 26 | $575 | $1,866 |
| Simple change of bladder tube | 23 | $70 | $243 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 23 | $138 | $434 |
| Biopsy of prostate gland | 22 | $102 | $333 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 18 | $345 | $2,066 |
| Imaging of urinary tract following injection of a contrast agent | 18 | $20 | $170 |
| Initial hospital admission, moderate complexity | 18 | $106 | $333 |
| Insertion of stent in ureter using an endoscope | 17 | $86 | $396 |
| Dilation of urethra using an endoscope | 15 | $111 | $387 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $37 | $114 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $54 | $189 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Payments are distributed across multiple categories with no single dominant type.
Geographic Context
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kumar is a clinical cardiology specialist, with above-average Medicare volume (top 26% in FL), and high industry engagement (mixed engagement, top 14%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kumar experienced with automated urinalysis?
Does Dr. Kumar receive payments from pharmaceutical companies?
How do Dr. Kumar's costs compare to other urology physicians in Lecanto?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology